growing number of cancer cases worldwide is driving the Tissue Microarray Market
Technavio analyzes that the Tissue Microarray Market is expected to grow at a CAGR of 5.8% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 2247.8 million.There are various factors that contribute to the growth of the market. The global incidence of cancer continues to rise, leading to a significant increase in demand for advanced diagnostic tools and therapeutic interventions. One such technology gaining popularity is Tissue Microarray (TMA), which facilitates high-throughput analysis of large tissue samples. The TMA market is poised for robust growth due to its potential in identifying biomarkers for personalized medicine and improving patient outcomes. This technology is expected to revolutionize cancer research and clinical practice, ultimately leading to better disease management and improved patient survival.
In the global tissue microarray market, hospitals represent a substantial end-user demographic. The significance of this sector stems from hospitals' pivotal role in disease diagnosis and research. Tissue microarrays enable hospitals to perform high-throughput analysis of protein and gene expression in thousands of tumor samples on a single slide using techniques such as immunohistochemistry (IHC), next-generation sequencing (NGS), and DNA microarray. This capability is particularly crucial in oncology, where the rapid and accurate assessment of biomarkers informs treatment decisions. Furthermore, hospitals maintain archival tissue blocks for extended periods, typically up to 20 years, providing an abundant source of material for constructing tissue microarrays. This long-term availability of samples bolsters the potential for retrospective studies linked to patient outcomes, thereby reinforcing tissue microarrays' indispensable role in clinical settings. Pharmaceutical companies and biotechnology firms also contribute significantly to the tissue microarray market, leveraging tissue microarrays for biomarker discovery, molecular diagnostics, and sample processing during the development of new drugs and therapies.
Know which region is leading the market growth by requesting a sample report
Tissue Microarray Market Segmentation
As per our research findings, here are some of the key competitors that are leading the industry
Find out what is trending in the market by accessing the free PDF report
The Tissue Microarray (TMA) market holds significance in molecular pathology, facilitating gene expression and protein localization studies through the use of molecular markers. TMAs play a crucial role in oncology research, particularly in understanding tumor heterogeneity and identifying biomarkers for clinical outcomes, therapeutic targets, and prognostic indicators. In clinical settings, TMAs aid in drug efficacy assessments and diagnostics development, including protein expression analysis via immunohistochemistry and biopsy samples. The market caters to cancer research, drug discovery, and the analysis of DNA, mRNA, protein levels, and spectroscopic data using automated analysis tools. Biotechnology companies, such as Pathology Innovation Incubator, leverage TMAs for high throughput screening in various cancer types, including prostate cancer, using paraffin blocks and tissue cores.
The Tissue Microarray (TMA) market is a significant segment of the larger life science tools and services market. This market focuses on the development of TMAs, which are essential tools for molecular pathology, enabling gene expression and protein localization studies, as well as the identification of molecular markers in oncology research. The increasing prevalence of tumor heterogeneity necessitates the use of TMAs for biomarker discovery, clinical outcomes assessment, therapeutic targets identification, and prognostic indicators determination. TMAs play a crucial role in drug efficacy evaluation and clinical setting applications, addressing genetic abnormalities and contributing to the advancement of personalized medicine. The global life science tools and services market's growth is driven by factors such as the increasing aging population, rising research and development expenditures, and the growing demand for precision medicine.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
